06.29.06
Cytomedix Announces Publication of the AutoloGel Diabetic Foot Ulcer Prospective Trial
Cytomedix Announces Publication of the AutoloGel Diabetic Foot Ulcer Prospective Trial ![]()
[Press Release] PrimeZone via Yahoo! Finance - Jun 28 5:00 AM
Cytomedix, Inc. , a biotechnology company specializing in developing and licensing systems for the treatment of non-healing chronic wounds including diabetic ulcers, today announced the publication of the results of its diabetic foot ulcer prospective trial for the AutoloGel System.


